Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Randomized Trial of 180 Degree vs. 360 Degree Selective Laser Trabeculoplasty as Initial Therapy for Glaucoma

NCT02628223 is registered in ClinicalTrials.gov with Temple University as lead sponsor.

NCT NCT02628223
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02628223 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Randomized Trial of 180 Degree vs. 360 Degree Selective Laser Trabeculoplasty as Initial Therapy for Glaucoma
Lead sponsor
Temple University
Phase
Not applicable
Overall status
Completed
Start date
September 30, 2014
Completion date
December 31, 2017
Enrollment
76 (actual)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

glaucoma, glaucoma, open angle, pseudo-exfoliative, ocular hypertension, open angle glaucoma, pigment dispersion syndrome